These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36893032)

  • 21. Tenecteplase for acute ischaemic stroke.
    Sandset EC; Tsivgoulis G
    Lancet; 2022 Jul; 400(10347):138-139. PubMed ID: 35779556
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence.
    Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K
    Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.
    Hailu K; Ragoonanan D; Davis H
    Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531
    [No Abstract]   [Full Text] [Related]  

  • 27. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 28. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
    Logallo N; Kvistad CE; Nacu A; Naess H; Waje-Andreassen U; Asmuss J; Aamodt AH; Lund C; Kurz MW; Rønning OM; Salvesen R; Idicula TT; Thomassen L
    BMC Neurol; 2014 May; 14():106. PubMed ID: 24886064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
    Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
    Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
    Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
    BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials.
    Bivard A; Huang X; Levi CR; Campbell BC; Cheripelli BK; Chen C; Kalladka D; Moreton FC; Ford I; Davis SM; Donnan GA; Muir KW; Parsons MW
    Int J Stroke; 2020 Jul; 15(5):507-515. PubMed ID: 31684841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
    George M; Baby N; Paul R; Zabeer M; Thomas C
    J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.
    Olindo S; Albucher JF; Bejot Y; Berge J; Cordonnier C; Guillon B; Sablot D; Tardy J; Alamowitch S; Sibon I
    Rev Neurol (Paris); 2023 Mar; 179(3):150-160. PubMed ID: 36369068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete recovery following intra-arterial tenecteplase administration in a woman with acute ischemic stroke.
    Meenakshi-Sundaram S; Periakaruppan A; Karuppiah SN; Karthik SN; Roopakumar L; Thembavani I
    J Clin Neurosci; 2013 Dec; 20(12):1786-8. PubMed ID: 23938013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenecteplase for Acute Ischemic Stroke: Current Evidence and Practical Considerations.
    Rabinstein AA; Golombievski E; Biller J
    CNS Drugs; 2020 Oct; 34(10):1009-1014. PubMed ID: 32785891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.